Skip to content

uniQure QURE Long-Term Debt

Long-Term Debt at other companies

Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$48.96M+15.3%
Precigen logo
PrecigenPGEN
$93.52M
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$585.47M
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$36.09M+74.5%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$100.19M
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's long-term debt?
uniQure (QURE) reported long-term debt of $49.94M in Q1 2026.
How has uniQure's long-term debt changed year-over-year?
uniQure's long-term debt decreased by 3.2% year-over-year, from $51.59M to $49.94M.
What is the long-term trend for uniQure's long-term debt?
Over 5 years (2020 to 2025), uniQure's long-term debt has grown at a 6.9% compound annual growth rate (CAGR), from $35.62M to $49.7M.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.